Medifast, Inc. Announces Fourth Quarter and Full Year 2018 Financial Results

Go back to Medifast, Inc. Announces Fourth Quarter and Full Year 2018 Financial Results

Medifast (MED) Tops Q4 EPS by 9c, Revenues Beat; Offers EPS/Revenue Guidance Above Consensus

February 26, 2019 4:35 PM EST

Medifast (NYSE: MED) reported Q4 EPS of $1.30, $0.09 better than the analyst estimate of $1.21. Revenue for the quarter came in at $145.8 million versus the consensus estimate of $142.86 million.

Revenue of $145.8 million, an increase of 87.0% year-over-yearActive earning Coaches of 24,100, an increase of 60.7% year-over-yearNet income of $15.7 million, an increase of 114.2% year-over-yearEarnings... More